Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Karan Gill, Master of Science
Senior Manager
Shionogi, United Kingdom
Disclosure(s): Shionogi BV: Employee
Poster(s):
(P-1352) Clinical Outcomes of Cefiderocol for Treatment of Bloodstream Infections Caused by Gram-Negative Bacteria: Subgroup Analysis of the PROVE Study
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1353) Earlier Cefiderocol Use was Associated with Better Outcomes for Challenging Gram-Negative Bacterial Infections: US Results From the Global Observational PROVE Study
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1354) Outcomes of Patients Treated With Cefiderocol For Infections Caused by β-Lactam–β-Lactamase Inhibitor Non-Susceptible Bacteria: Subgroup Analysis of the PROVE Study
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
